Phase 1 Study Of The Axl Inhibitor Ds-1205 In Combination With Osimertinib In Subjects With Metastatic Or Unresectable Egfr-Mutant Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
NSCLC, AXL, EGFR Mutant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF THORACIC ONCOLOGY(2021)